Choroidal Neovascularization: all 214 studies
Page 2 of 3. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.
- Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal NeovascularizationCompletedNCT03042871Phase 4
- Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMDCompletedNCT03024424Not applicable
- Episcleral Brachytherapy for the Treatment of Wet AMDActive, not recruitingNCT02988895Not applicable
- Conbercept in Choroidal Neovascularization Secondary to UveitisStatus unknownNCT02934841Phase 2
- Genetic Factors of Idiopathic Polypoidal Vasculopathies in the ATM Gene (Ataxia Telangiectasia Mutated)TerminatedNCT02857894
- Intravitreal Conbercept for Idiopathic Choroidal NeovascularizationStatus unknownNCT02857517Phase 2
- Prospective Observational Study to Assess Effectiveness of Intravitreal Aflibercept in Patients With Wet Macular Degeneration in GreeceCompletedNCT02821247
- Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMDStatus unknownNCT02727881Phase 3
- Resveratrol for Exudative Age-Related Macular DegenerationTerminatedNCT02625376Not applicable
- Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients (ASTRID).WithdrawnNCT02573038Phase 2
- Study Evaluating the Efficacy of Aflibercept for the Treatment of Inflammatory CNV in Young Patients (ALINEA).CompletedNCT02556229Phase 2
- Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE)CompletedNCT02537054Phase 2
- Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF InjectionStatus unknownNCT02486484Phase 2
- Efficacy of Aflibercept (Eylea®) on Choroidal Neovascularization (Type 3)CompletedNCT02320474Phase 4
- Retinal Therapy Guided by 3D OCT Image AnalysisCompletedNCT02308215
- Special Drug Use Investigation of EYLEA for Myopic Choroidal NeovascularizationCompletedNCT02260687
- Study Evaluating the Efficacy of Aflibercept for the Treatment of NVCI in Young PatientsCompletedNCT02257502Phase 2
- VEGF and PEDF in Patients With Myopic Choroidal NeovascularizationCompletedNCT02175940
- Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular DegenerationCompletedNCT02060604Phase 4
- Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macular DegenerationWithdrawnNCT02036723Phase 3
- Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective StudyCompletedNCT02015351Not applicable
- International Cancer of the Head and Neck, Genetics and Environment (InterCHANGE) StudyStatus unknownNCT01972802
- Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMDCompletedNCT01880788
- Impact of Home Monitoring to Decrease the Treatment Burden for Neovascular Age-related Macular Degeneration (AMD)CompletedNCT01863199Phase 4
- Intravitreal Anti-VEGF in Exudative AMD With Epiretinal MembranesCompletedNCT01846351
- A Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients With mCNVStatus unknownNCT01809223Phase 3
- Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High MyopiaCompletedNCT01716026Phase 3
- A Population-based Study of Macular Choroidal Neovascularization in a Chinese PopulationCompletedNCT01666821
- Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal VasculopathyWithdrawnNCT01666236Phase 4
- Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular DegenerationCompletedNCT01628354Phase 4
- Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis SyndromeCompletedNCT01578720Phase 1
- Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular DegenerationCompletedNCT01570790Phase 1/2
- A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD)CompletedNCT01542866Not applicable
- A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the EyeStatus unknownNCT01531842Not applicable
- PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)CompletedNCT01445899Phase 2
- A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMDCompletedNCT01436864Phase 3
- Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic MyopiaCompletedNCT01423149Phase 2
- Comparison Between Home Macular Perimeter and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)WithdrawnNCT01336907
- Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular Age Related Macular DegenerationCompletedNCT01334294
- Bevacizumab Effect on Blood VelocityCompletedNCT01298440
- Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab TherapyCompletedNCT01256632Not applicable
- Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMDWithdrawnNCT01256580Not applicable
- Intravitreal LFG316 in Patients With Advanced Age-related Macular DegenerationCompletedNCT01255462Phase 1
- A Study Assessing the Safety and Efficacy of Multiple Intravitreal KH902 in Patients With CNV Due to AMDCompletedNCT01242254Phase 1/2
- Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular DegenerationCompletedNCT01162746Phase 2
- A Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular AMDCompletedNCT01157715Phase 2
- A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular DegenerationCompletedNCT01154062Phase 1
- Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular DegenerationCompletedNCT01136252Phase 2
- Evaluation of Optical Coherence Tomography.CompletedNCT01080898
- A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in HumansCompletedNCT01051700Phase 1
- Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized RegimenCompletedNCT01037348Phase 2
- Use of Spectral OCT in Combination TherapyCompletedNCT01025063
- Foresee Home for Monitoring Age Related Macular Degeneration (AMD)CompletedNCT01010997
- Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High MyopiaCompletedNCT00967850Phase 3
- A Study Of Early Markers Of Choroidal NeovascularizationTerminatedNCT00902785
- Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot StudyStatus unknownNCT00855608Phase 1
- Does Vascular Endothelial Growth Factor (VEGF) or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With Choroidal NeoVascularization (CNV)?WithdrawnNCT00813514Not applicable
- Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular DegenerationTerminatedNCT00766337Phase 2
- Ranibizumab for Treating Submacular Vascularized Pigment Epithelial DetachmentsCompletedNCT00749021Phase 1
- Usability of the Foresee Home in Intermediate Age Related Macular Degeneration (AMD) PatientsCompletedNCT00748384
- Study of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (Wet AMD)CompletedNCT00725686Phase 1
- Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular DegenerationTerminatedNCT00712491Phase 1/2
- Photodynamic Therapy Combined With Bevacizumab vs Bevacizumab Alone for Neovascular Age-related Macular DegenerationWithdrawnNCT00696592Phase 2
- Retinal Effects After Combined Photodynamic Therapy (PDT) With Intravitreal TriamcinoloneCompletedNCT00685100Phase 3
- High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular DegenerationCompletedNCT00656903
- Sensitivity of the Home Macular Perimeter (HMP)CompletedNCT00604071
- Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP)CompletedNCT00603850
- Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid StreaksTerminatedNCT00599820Phase 3
- Usage of the Home Macular Perimeter (HMP)CompletedNCT00596388
- Photodynamic and Pharmacologic Treatment of CNVCompletedNCT00570193Phase 1/2
- Stratus Versus Cirrus OCT in AMDStatus unknownNCT00568191
- Evolution of Visual Impairment During Pseudoxanthoma ElasticumCompletedNCT00555113
- Evaluation of Dosing Interval of Higher Doses of RanibizumabCompletedNCT00533520Phase 4
- Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate)CompletedNCT00523406Phase 3
- Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)CompletedNCT00510965Phase 2
- Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMDTerminatedNCT00509548Phase 2
- Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular DegenerationCompletedNCT00504959Phase 4
- CAPTAIN:Choroidal Neovascularization Assessment by Pattern ElectroretinographyCompletedNCT00500344Phase 1
- EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)CompletedNCT00470678Phase 3
- A Study To Evaluate The Safety, Tolerability And Pk Of Pazopanib Eye Drops In Healthy Adult And Elderly Subjects.CompletedNCT00463320Phase 1
- Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNVCompletedNCT00429962Phase 3
- Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMDCompletedNCT00426998Phase 2
- Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV)CompletedNCT00424710Phase 1
- Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)CompletedNCT00417846
- Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)TreatmentTerminatedNCT00417833Phase 2/3
- Intraocular Pressure Immediately Following Intravitreous Injection of RanibizumabCompletedNCT00417703
- Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)CompletedNCT00407719Phase 1
- Efficacy of Retreatments With Intravitreal BevacizumabTerminatedNCT00406744Phase 3
- Intravitreal Bevacizumab in Agioid StreaksCompletedNCT00406250Phase 1
- Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular DegenerationWithdrawnNCT00403156Phase 1
- Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.CompletedNCT00395551Phase 1
- Avastin for CNV Secondary to Pattern DystrophyStatus unknownNCT00391144Phase 2/3
- Combination Therapy for Age-Related Macular Degeneration.CompletedNCT00376701Phase 2
- Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)CompletedNCT00370786Phase 3
- A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)CompletedNCT00363714Phase 1/2
- Genetic Study of Age-Related Macular DegenerationCompletedNCT00357578
- Myopic Macular HaemorrhagesCompletedNCT00345228
- Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous MaculopathyStatus unknownNCT00344617Phase 3
- Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT)CompletedNCT00305630Phase 2/3
- Macugen for HistoplasmosisTerminatedNCT00272766Not applicable